TipRanks
Metlife (DE:MWZ)
XETRA:MWZ
Germany Market

Metlife (MWZ) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

MWZ Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Metlife
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MWZ Stock 12 Month Forecast

Average Price Target

€99.36
▲(19.57% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is €99.36 with a high forecast of €106.00 and a low forecast of €96.20. The average price target represents a 19.57% change from the last price of €83.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"€59","71":"€71","83":"€83","95":"€95","107":"€107"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106.00278668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€106.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":99.36242876727275,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€99.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.20420976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€96.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,71,83,95,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.76,84.54790666769232,86.33581333538461,88.12372000307693,89.91162667076924,91.69953333846155,93.48744000615385,95.27534667384616,97.06325334153846,98.85116000923077,100.63906667692308,102.42697334461539,104.21488001230769,{"y":106.00278668,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.76,84.03710990517483,85.31421981034966,86.59132971552448,87.8684396206993,89.14554952587413,90.42265943104897,91.6997693362238,92.97687924139862,94.25398914657345,95.53109905174827,96.8082089569231,98.08531886209792,{"y":99.36242876727275,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.76,83.79416998153846,84.82833996307693,85.86250994461538,86.89667992615385,87.9308499076923,88.96501988923077,89.99918987076923,91.0333598523077,92.06752983384615,93.10169981538462,94.13586979692307,95.17003977846154,{"y":96.20420976,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":68.502,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.053,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.874,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.488,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.186,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.462,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.555,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.103,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.165,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.928,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.543,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.48,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.76,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€106.00Average Price Target€99.36Lowest Price Target€96.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
€97.99→€101.55
Buy
22.20%
Upside
Reiterated
10/21/26
MetLife price target raised to $114 from $110 at TD CowenMetLife price target raised to $114 from $110 at TD Cowen
J.P. Morgan Analyst forecast on DE:MWZ
J.P. Morgan
J.P. Morgan
€96.2→€97.99
Buy
17.91%
Upside
Assigned
10/15/26
MetLife price target raised to $110 from $108 at JPMorganMetLife price target raised to $110 from $108 at JPMorgan
Piper Sandler Analyst forecast on DE:MWZ
Piper Sandler
Piper Sandler
€97.99
Buy
17.91%
Upside
Reiterated
10/12/26
Metlife (MET) Receives a Buy from Piper Sandler
Bank of America Securities Analyst forecast on DE:MWZ
Bank of America Securities
Bank of America Securities
€106
Buy
27.56%
Upside
Reiterated
10/12/26
Bank of America Securities Reaffirms Their Buy Rating on Metlife (MET)
Wells Fargo
€97.09→€97.99
Buy
17.91%
Upside
Reiterated
10/12/26
Analysts Conflicted on These Financial Names: Metlife (NYSE: MET) and Baldwin Insurance Group (NASDAQ: BWIN)
KBW
€96.2
Buy
15.77%
Upside
Reiterated
10/08/26
KBW Keeps Their Buy Rating on Metlife (MET)
Mizuho Securities Analyst forecast on DE:MWZ
Mizuho Securities
Mizuho Securities
€99.77→€97.09
Buy
16.84%
Upside
Reiterated
10/07/26
MetLife price target lowered to $109 from $112 at MizuhoMetLife price target lowered to $109 from $112 at Mizuho
Barclays Analyst forecast on DE:MWZ
Barclays
Barclays
€86.41→€98.88
Buy
18.99%
Upside
Reiterated
10/07/26
Barclays Sticks to Its Buy Rating for Metlife (MET)
UBS
€93.53→€97.99
Buy
17.91%
Upside
Reiterated
10/06/26
MetLife price target raised to $110 from $105 at UBSMetLife price target raised to $110 from $105 at UBS
Morgan Stanley Analyst forecast on DE:MWZ
Morgan Stanley
Morgan Stanley
€98.88
Buy
18.99%
Upside
Assigned
10/05/26
Morgan Stanley Gives a Buy Rating to Metlife (MET)
Jefferies Analyst forecast on DE:MWZ
Jefferies
Jefferies
€91.75→€102.44
Buy
23.27%
Upside
Reiterated
10/01/26
Jefferies Reaffirms Their Buy Rating on Metlife (MET)
Raymond James Analyst forecast on DE:MWZ
Raymond James
Raymond James
―
Hold
―
Reiterated
09/29/26
Analysts Offer Insights on Financial Companies: Metlife (NYSE: MET) and Robinhood (NASDAQ: HOOD)
Evercore ISI Analyst forecast on DE:MWZ
Evercore ISI
Evercore ISI
€84.62→€85.51
Hold
2.91%
Upside
Reiterated
04/09/26
MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI
Argus Research Analyst forecast on DE:MWZ
Argus Research
Argus Research
€80.17
Buy
-3.53%
Downside
Reiterated
12/08/25
MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
€97.99→€101.55
Buy
22.20%
Upside
Reiterated
10/21/26
MetLife price target raised to $114 from $110 at TD CowenMetLife price target raised to $114 from $110 at TD Cowen
J.P. Morgan Analyst forecast on DE:MWZ
J.P. Morgan
J.P. Morgan
€96.2→€97.99
Buy
17.91%
Upside
Assigned
10/15/26
MetLife price target raised to $110 from $108 at JPMorganMetLife price target raised to $110 from $108 at JPMorgan
Piper Sandler Analyst forecast on DE:MWZ
Piper Sandler
Piper Sandler
€97.99
Buy
17.91%
Upside
Reiterated
10/12/26
Metlife (MET) Receives a Buy from Piper Sandler
Bank of America Securities Analyst forecast on DE:MWZ
Bank of America Securities
Bank of America Securities
€106
Buy
27.56%
Upside
Reiterated
10/12/26
Bank of America Securities Reaffirms Their Buy Rating on Metlife (MET)
Wells Fargo
€97.09→€97.99
Buy
17.91%
Upside
Reiterated
10/12/26
Analysts Conflicted on These Financial Names: Metlife (NYSE: MET) and Baldwin Insurance Group (NASDAQ: BWIN)
KBW
€96.2
Buy
15.77%
Upside
Reiterated
10/08/26
KBW Keeps Their Buy Rating on Metlife (MET)
Mizuho Securities Analyst forecast on DE:MWZ
Mizuho Securities
Mizuho Securities
€99.77→€97.09
Buy
16.84%
Upside
Reiterated
10/07/26
MetLife price target lowered to $109 from $112 at MizuhoMetLife price target lowered to $109 from $112 at Mizuho
Barclays Analyst forecast on DE:MWZ
Barclays
Barclays
€86.41→€98.88
Buy
18.99%
Upside
Reiterated
10/07/26
Barclays Sticks to Its Buy Rating for Metlife (MET)
UBS
€93.53→€97.99
Buy
17.91%
Upside
Reiterated
10/06/26
MetLife price target raised to $110 from $105 at UBSMetLife price target raised to $110 from $105 at UBS
Morgan Stanley Analyst forecast on DE:MWZ
Morgan Stanley
Morgan Stanley
€98.88
Buy
18.99%
Upside
Assigned
10/05/26
Morgan Stanley Gives a Buy Rating to Metlife (MET)
Jefferies Analyst forecast on DE:MWZ
Jefferies
Jefferies
€91.75→€102.44
Buy
23.27%
Upside
Reiterated
10/01/26
Jefferies Reaffirms Their Buy Rating on Metlife (MET)
Raymond James Analyst forecast on DE:MWZ
Raymond James
Raymond James
―
Hold
―
Reiterated
09/29/26
Analysts Offer Insights on Financial Companies: Metlife (NYSE: MET) and Robinhood (NASDAQ: HOOD)
Evercore ISI Analyst forecast on DE:MWZ
Evercore ISI
Evercore ISI
€84.62→€85.51
Hold
2.91%
Upside
Reiterated
04/09/26
MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI
Argus Research Analyst forecast on DE:MWZ
Argus Research
Argus Research
€80.17
Buy
-3.53%
Downside
Reiterated
12/08/25
MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus
Stocks with the Highest Top Analyst Consensus in the Financial Sector
BNBrookfield Corporation
SSBSouthState Corporation
RIOTRiot Platforms
AIZAssurant
BETRBetter Home & Finance
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

3 Months
Success Rate
25/36 ratings generated profit
69%
Average Return
+7.24%
Copying Ryan Krueger's trades and holding each position for 3 Months would result in 69.44% of your transactions generating a profit, with an average return of +7.24% per trade.
1 Year
Success Rate
32/36 ratings generated profit
89%
Average Return
+18.02%
Copying Ryan Krueger's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +18.02% per trade.
2 Years
Alex ScottBarclays
Success Rate
18/18 ratings generated profit
100%
Average Return
+28.60%
Copying Alex Scott's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MWZ Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
15
19
19
20
22
Hold
7
5
3
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
24
22
22
24
In the current month, MWZ has received 22 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MWZ average Analyst price target in the past 3 months is 99.36.
Each month's total comprises the sum of three months' worth of ratings.

MWZ Financial Forecast

MWZ Earnings Forecast

Next quarter’s earnings estimate for MWZ is €2.47 with a range of €2.33 to €2.59. The previous quarter’s EPS was €2.16. MWZ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 81.82% of the time in the same period. In the last calendar year MWZ has Performed in-line its overall industry.
Next quarter’s earnings estimate for MWZ is €2.47 with a range of €2.33 to €2.59. The previous quarter’s EPS was €2.16. MWZ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 81.82% of the time in the same period. In the last calendar year MWZ has Performed in-line its overall industry.

MWZ Sales Forecast

Next quarter’s sales forecast for MWZ is €17.68B with a range of €17.10B to €18.02B. The previous quarter’s sales results were €17.19B. MWZ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 93.33% of the time in the same period. In the last calendar year MWZ has Performed in-line its overall industry.
Next quarter’s sales forecast for MWZ is €17.68B with a range of €17.10B to €18.02B. The previous quarter’s sales results were €17.19B. MWZ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 93.33% of the time in the same period. In the last calendar year MWZ has Performed in-line its overall industry.

MWZ Stock Forecast FAQ

What is DE:MWZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Metlife’s 12-month average price target is 99.36.
    What is DE:MWZ’s upside potential, based on the analysts’ average price target?
    Metlife has 19.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Metlife a Buy, Sell or Hold?
          Metlife has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Metlife’s share price target?
            The average share price target for Metlife is 99.36. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €106.00 ,and the lowest forecast is €96.20. The average share price target represents 19.57% Increase from the current price of €83.1.
              What do analysts say about Metlife?
              Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Metlife?
                To buy shares of DE:MWZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.